KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Liabilities and Shareholders Equity (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $405.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 1.6% to $405.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 billion, a 1.45% increase, with the full-year FY2025 number at $405.9 million, up 1.6% from a year prior.
  • Liabilities and Shareholders Equity was $405.9 million for Q4 2025 at Biolife Solutions, up from $392.1 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $559.4 million in Q3 2021 to a low of $240.0 million in Q1 2021.
  • A 5-year average of $433.5 million and a median of $411.9 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 357.11% in 2021, then dropped 18.77% in 2022.
  • Biolife Solutions' Liabilities and Shareholders Equity stood at $554.3 million in 2021, then dropped by 18.77% to $450.2 million in 2022, then dropped by 8.33% to $412.7 million in 2023, then fell by 3.2% to $399.5 million in 2024, then grew by 1.6% to $405.9 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Liabilities and Shareholders Equity are $405.9 million (Q4 2025), $392.1 million (Q3 2025), and $387.2 million (Q2 2025).